MICHAEL SNEDEKER: Open Payments
NPI 1780954206 · GRANVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 116 payments from 16 companies in 2025. Trend: 2023 $1,742 · 2024 $2,973 · 2025 $1,780
Food & beverage: $1,689Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $485 |
| UCB, Inc. | 15 | $295 |
| Janssen Biotech, Inc. | 16 | $206 |
| Galderma Laboratories, L.P. | 12 | $154 |
| Incyte Corporation | 9 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Organon LLC | 4 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: Bimzelx, SKYRIZI, RINVOQ, TREMFYA, OPZELURA, NEMLUVIO, DUPIXENT, ILUMYA.
Industry payments across OH — which companies pay providers there.
